In addition, some studies have reported that decreased β1 integrin protein expression is associated with more aggressive breast cancer types [174,175], whereas other studies could not verify a significant correlation between integrin subunit β1 (ITGB1) protein expression and survival of patients with breast carcinoma [176,177]. Here, ITGB1 is linked to breast carcinoma.